Cargando…

Cholesterol-rich lipid-mediated nanoparticles boost of transfection efficiency, utilized for gene editing by CRISPR-Cas9

Purpose: Gene therapy has become a promising remedy to treat disease by modifying the person’s genes. The therapeutic potential of related tools such as CRISPR-Cas9 depends on the efficiency of delivery to the targeted cells. Numerous transfection reagents have been designed and lots of efforts have...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hosseini, Elaheh Sadat, Nikkhah, Maryam, Hosseinkhani, Saman
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Dove 2019
Materias:	Original Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6579871/ https://www.ncbi.nlm.nih.gov/pubmed/31354265 http://dx.doi.org/10.2147/IJN.S199104

Ejemplares similares

Apoptosome formation upon overexpression of native and truncated Apaf-1 in cell-free and cell-based systems
por: Noori, Ali Reza, et al.
Publicado: (2018)

Preparation, characterization, and efficient transfection of cationic liposomes and nanomagnetic cationic liposomes
por: Samadikhah, Hamid Reza, et al.
Publicado: (2011)

TRAIL/S-layer/graphene quantum dot nanohybrid enhanced stability and anticancer activity of TRAIL on colon cancer cells
por: Lotfollahzadeh, Shima, et al.
Publicado: (2022)

Clinical applications of the CRISPR/Cas9 genome-editing system: Delivery options and challenges in precision medicine
por: Khoshandam, Mohadeseh, et al.
Publicado: (2023)

A review of emerging physical transfection methods for CRISPR/Cas9-mediated gene editing
por: Fajrial, Apresio K., et al.
Publicado: (2020)

In Vitro CRISPR/Cas9 Transfection and Gene-Editing Mediated by Multivalent Cationic Liposome–DNA Complexes
por: Sousa, Diana A., et al.
Publicado: (2022)

Engineered circular guide RNAs boost CRISPR/Cas12a- and CRISPR/Cas13d-based DNA and RNA editing
por: Zhang, Xin, et al.
Publicado: (2023)

Investigation of the effects of carbon-based nanomaterials on A53T alpha-synuclein aggregation using a whole-cell recombinant biosensor
por: Mohammadi, Soheila, et al.
Publicado: (2017)

Optimization of Experimental Variables Influencing Apoptosome Biosensor in HEK293T Cells
por: Oladzad, Azarakhsh, et al.
Publicado: (2020)

Label-Free and Bioluminescence-Based Nano-Biosensor for ATP Detection
por: Karimi, Elham, et al.
Publicado: (2022)

CRISPR-Cas12a delivery by DNA-mediated bioresponsive editing for cholesterol regulation
por: Sun, Wujin, et al.
Publicado: (2020)

Boosting plant immunity with CRISPR/Cas
por: Chaparro-Garcia, Angela, et al.
Publicado: (2015)

CRISPR/Cas9 Delivery Mediated with Hydroxyl‐Rich Nanosystems for Gene Editing in Aorta
por: Zhang, Xiaoping, et al.
Publicado: (2019)

A ribonucleoprotein transfection strategy for CRISPR/Cas9‐mediated gene editing and single cell cloning in rainbow trout cells
por: Zoppo, Marina, et al.
Publicado: (2021)

CRISPR/Cas9 ribonucleoprotein (RNP) complex enables higher viability of transfected cells in genome editing of acute myeloid cells
por: Cheng, Qinquan, et al.
Publicado: (2022)

Lipid-Nanoparticle-Based Delivery of CRISPR/Cas9 Genome-Editing Components
por: Kazemian, Pardis, et al.
Publicado: (2022)

CRISPR-Cas9 DNA Base-Editing and Prime-Editing
por: Kantor, Ariel, et al.
Publicado: (2020)

CRISPR-Cas9 delivery to hard-to-transfect cells via membrane deformation
por: Han, Xin, et al.
Publicado: (2015)

CRISPR-Cas9 genome editing using targeted lipid nanoparticles for cancer therapy
por: Rosenblum, Daniel, et al.
Publicado: (2020)

Latest Developed Strategies to Minimize the Off-Target Effects in CRISPR-Cas-Mediated Genome Editing
por: Naeem, Muhammad, et al.
Publicado: (2020)

Commentary: RNA editing with CRISPR-Cas13
por: Matsoukas, Ianis G.
Publicado: (2018)

Genome Editing in Bacteria: CRISPR-Cas and Beyond
por: Arroyo-Olarte, Ruben D., et al.
Publicado: (2021)

CRISPR/Cas9 or prime editing? – It depends on…
por: Schenke, Dirk
Publicado: (2020)

Simultaneous Gene Delivery and Tracking through Preparation of Photo-Luminescent Nanoparticles Based on Graphene Quantum Dots and Chimeric Peptides
por: Ghafary, Soroush Moasses, et al.
Publicado: (2017)

In Vitro Pre-validation of Gene Editing by CRISPR/Cas9 Ribonucleoprotein
por: Mehravar, Maryam, et al.
Publicado: (2019)

Improvement of CRISPR/Cas9 system by transfecting Cas9-expressing Plasmodium berghei with linear donor template
por: Shinzawa, Naoaki, et al.
Publicado: (2020)

Lipid nanoparticle-mediated CRISPR/Cas9 gene editing and metabolic engineering for anticancer immunotherapy
por: Ju, Hyemin, et al.
Publicado: (2022)

Reversible RNA acylation for control of CRISPR–Cas9 gene editing
por: Habibian, Maryam, et al.
Publicado: (2019)

Inducible in vivo genome editing with CRISPR/Cas9
por: Dow, Lukas E, et al.
Publicado: (2015)

The Rise of CRISPR/Cas for Genome Editing in Stem Cells
por: Shui, Bing, et al.
Publicado: (2016)

Efficient Mitochondrial Genome Editing by CRISPR/Cas9
por: Jo, Areum, et al.
Publicado: (2015)

Multiplex genome editing of microorganisms using CRISPR-Cas
por: Adiego-Pérez, Belén, et al.
Publicado: (2019)

CRISPR/Cas9: Transcending the Reality of Genome Editing
por: Chira, Sergiu, et al.
Publicado: (2017)

Genome Editing in Cotton with the CRISPR/Cas9 System
por: Gao, Wei, et al.
Publicado: (2017)

Delivery Aspects of CRISPR/Cas for in Vivo Genome Editing
por: Wilbie, Danny, et al.
Publicado: (2019)

Applications of the CRISPR/Cas system beyond gene editing
por: Anton, Tobias, et al.
Publicado: (2018)

CRISPR/Cas9 Editing for Gaucher Disease Modelling
por: Pavan, Eleonora, et al.
Publicado: (2020)

Spatiotemporal control of CRISPR/Cas9 gene editing
por: Zhuo, Chenya, et al.
Publicado: (2021)

Nanoparticle Delivery of CRISPR/Cas9 for Genome Editing
por: Duan, Li, et al.
Publicado: (2021)

CRISPR–Cas9 Based Bacteriophage Genome Editing
por: Zhang, Xueli, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_n410oi7usn2u9u4b50vmml9akc